Eye Infection Linked to Alzheimer’s Disease Risk

A common bacterium, Chlamydia pneumoniae, typically known for causing pneumonia and sinus infections, may play a surprising role in the development of Alzheimer’s disease. New research from Cedars-Sinai suggests this bacterium can persist in both the eye and the brain for years, potentially worsening the damage associated with the neurodegenerative condition. Cedars-Sinai researchers published their findings in Nature Communications on February 21, 2026.

The Connection Between Chlamydia pneumoniae and Alzheimer’s

The study reveals that Chlamydia pneumoniae can travel to the retina, the light-sensitive tissue at the back of the eye. Once there, it triggers immune responses that contribute to inflammation, nerve cell death and cognitive decline. ScienceDaily reports that this discovery suggests chronic infection and inflammation could be key drivers of Alzheimer’s disease.

Research Findings

Researchers analyzed retinal tissue from 104 individuals, including those with normal cognition, mild cognitive impairment, and Alzheimer’s disease. They found significantly higher levels of Chlamydia pneumoniae in the retinas and brains of people diagnosed with Alzheimer’s compared to those with normal cognitive function. Higher bacterial levels were also associated with more severe brain damage and accelerated cognitive decline. SciTechDaily highlights that the bacterium evades immune defenses, leading to chronic, low-level inflammation.

APOE4 Gene and Increased Risk

The research also indicated that elevated bacterial levels were particularly common in individuals carrying the APOE4 gene variant, a known risk factor for developing Alzheimer’s disease.

Laboratory and Animal Studies

To further investigate the link, scientists conducted experiments on human nerve cells in the lab and studied mice with Alzheimer’s disease. In both models, infection with Chlamydia pneumoniae resulted in increased inflammation, greater nerve cell death, and worsened cognitive problems. The infection also stimulated the production of amyloid-beta, the protein that accumulates in the brains of Alzheimer’s patients.

Potential Therapeutic Approaches

These findings suggest that targeting the infection-inflammation pathway could offer new therapeutic strategies for Alzheimer’s disease. Potential approaches include early antibiotic use and therapies designed to reduce inflammation. The study also supports the idea of using retinal imaging as a noninvasive method to identify individuals at risk for Alzheimer’s disease.

The Eye as a Window to the Brain

“Seeing Chlamydia pneumoniae consistently across human tissues, cell cultures and animal models allowed us to identify a previously unrecognized link between bacterial infection, inflammation and neurodegeneration,” said Maya Koronyo-Hamaoui, PhD, professor of Neurosurgery, Neurology, and Biomedical Sciences at Cedars-Sinai Health Sciences University. “The eye is a surrogate for the brain, and this study shows that retinal bacterial infection and chronic inflammation can reflect brain pathology and predict disease status.”

Further research is needed to fully understand the complex relationship between Chlamydia pneumoniae and Alzheimer’s disease, but these findings offer a promising new avenue for prevention and treatment.